TriAltus Bioscience to Present Abstract on Single-Step Cas9 Protein Purification with CL7/Im7 Affinity Tag System at PepTalk 2020
BIRMINGHAM, Ala.–(BUSINESS WIRE)– TriAltus Bioscience, LLC, transforming protein-based research, announced its participation and poster presentation at the 19th annual PepTalk: The Protein Science Week. The PepTalk 2020 conference, one of the largest annual gatherings of protein science researchers in the world, will be held January 20 – 24 at the Hilton San Diego Bayfront.
BIRMINGHAM, Ala. – TriAltus Bioscience, LLC today announced the launch of its Activated Im7 affinity chromatography resin for the CL7/Im7 protein purification system. This new version more than doubles the single-step protein purification system’s original binding capacity from 15 – 20 mg/ml to 35 – 40 mg/ml of CL7-tagged protein. Read more.
Chinese Scientists Use TriAltus Bioscience’s CL-7 Purification System to Purify CRISPR-associated Proteins
BIRMINGHAM, Ala. (August 29, 2018)—TriAltus Bioscience, LLC today announced that scientists at Hubei University in China successfully co-expressed and purified ribonucleoprotein complexes—including Cas9 and Cas12a CRISPR-associated proteins—from E. coli in a single step using the company’s licensed CL-7 purification technology. The Hubei scientists published the results of their work in late July. “This team’s success […]
TriAltus Bioscience Announces Licensing Agreement with UAB and Begins to Commercialize Novel Protein Purification Technology
New method saves time, increases yield and purity, and reduces protein preparation costs TriAltus Bioscience, LLC today announced that it has licensed a novel protein purification platform from The University of Alabama at Birmingham (UAB) and is already working to commercialize the technology. The terms of the agreement were not disclosed.
Stay up-to-date with the latest news, updates, and research from TriAltus and the world of proteins!